Simon Goodall is a Vice President in the Los Angeles office of The Boston Consulting Group. He is the co-leader of BCGs global Biopharma R&D business and has worked extensively in big pharma, biotech and specialty pharma R&D as well as with medical technology companies and healthcare payers and providers. Mr. Goodall has published broadly on the above topics and is also a regular speaker at industry conferences. His recent publications include "The Promise of the East: India and China as R&D Options" in Nature Biotechnology, and a series of BCG publications on the topic of "Rising to the Productivity Challenge in Biopharma R&D". Mr. Goodall is also a key member of the leadership team for BCG's LA office and is responsible for training and development for the 75 BCG professional staff in BCG LA.
Simon Goodall is a Vice President in the Los Angeles office of The Boston Consulting Group. He is the co-leader of BCGs global Biopharma R&D business and has worked extensively in big pharma, biotech and specialty pharma R&D as well as with medical technology companies and healthcare payers and providers. Mr. Goodall has published broadly on the above topics and is also a regular speaker at industry conferences. His recent publications include "The Promise of the East: India and China as R&D Options" in Nature Biotechnology, and a series of BCG publications on the topic of "Rising to the Productivity Challenge in Biopharma R&D". Mr. Goodall is also a key member of the leadership team for BCG's LA office and is responsible for training and development for the 75 BCG professional staff in BCG LA.
